FDA inspections under QMSR: the changes you need to be ready for

Presenter: Eric Henry, Brooke & Associates

QSIT may be on the way out, but what does that actually mean for your next FDA inspection?

In this webinar, we’ll break down what FDA’s updated Compliance Program Manual signals about QMSR inspections, including the inspection models that may be used in different scenarios, how remote regulatory assessments (RRAs) fit into FDA oversight, and what MDSAP means for surveillance expectations. You’ll leave with a clearer picture of what’s changing, what’s staying the same, and what to prioritize now to stay inspection-ready.

What you’ll learn:

  • What “QSIT is obsolete” really changes - and what it doesn’t
  • The inspection models described in FDA’s Compliance Program Manual and when each may apply
  • Remote activity clarified: inspections vs RRAs and what to expect if you get one
  • Where MDSAP fits in the updated audit and surveillance landscape
  • A practical readiness focus list for avoiding surprises during your next FDA interaction

Watch now!

FDA inspections under QMSR: the changes you need to be ready for
Who should attend?
  • Quality and regulatory professionals
  • Medtech founders and executives
  • Product development managers
Register Now  

Featured In